A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 4773
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : apo
Long Form : apolipoprotein
No. Year Title Co-occurring Abbreviation
2020 A placebo-controlled proof-of-concept study of alirocumab on postprandial lipids and vascular elasticity in insulin-treated patients with type 2 diabetes mellitus. AUC, CVD, LDL-C, PCSK9, T2DM, TG, VLDL
2020 Anti-depressive effects of Kai-Xin-San on lipid metabolism in depressed patients and CUMS rats using metabolomic analysis. CUMS, DPs, FFA, HCs, HDL-C, KXS, KXS, MMPs, PLTP, PON1, ROC, TCH, TG
2020 Antiatherogenic properties of high-density lipoproteins from arterial plasma are attenuated as compared to their counterparts of venous origin. HDL, LDLs
2020 APOE-amyloid interaction: Therapeutic targets. AD
2020 Assembly and Characterization of Biocompatible Coenzyme Q10 -Enriched Lipid Nanoparticles. CoQ10, ND, PtdCho
2020 Association between obstructive sleep apnea and lipid metabolism during REM and NREM Sleep. AHIs, HDL-C, LDL-C, NREM, OSA, REM, TC, TG
2020 Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study. HDL, PFAS, PFDA, PFHxS, PFNA, PFOA, PFOS, POUNDS, SE
2020 Dietary fructose and dyslipidemia: new mechanisms involving apolipoprotein CIII. ---
2020 Effects of Lactobacillus plantarum Q180 on Postprandial Lipid Levels and Intestinal Environment: A Double-Blind, Randomized, Placebo-Controlled, Parallel Trial. AUC, LPQ180, TG
10  2020 Emerging well-tailored nanoparticulate delivery system based on in situ regulation of the protein corona. NP, RBP4, VEGF
11  2020 HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. ACLD, ACLF, AD, HDL-C, HDL-C
12  2020 Hypobetalipoproteinemia and abetalipoproteinemia: liver disease and cardiovascular disease. ABL, FHBL, LDL-C, PCSK9
13  2020 Impact of Grape Products on Lipid Profile: A Meta-Analysis of Randomized Controlled Studies. HDL-C, LDL-C, MD, oxLDL-C, RCTs, TC, TG
14  2020 Lactonase Activity, Status, and Genetic Variations of Paraoxonase 1 in Women with Gestational Diabetes Mellitus. DEPCyMC, GDM, MDA, NLA, PON1, TAC, TBBL, TOS
15  2020 Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule. CVD
16  2020 Milk polar lipids reduce lipid cardiovascular risk factors in overweight postmenopausal women: towards a gut sphingomyelin-cholesterol interplay. PL
17  2020 Molecular Mechanisms of the Interactions of N-(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins. AUC, Fbg, HPMA, HSA, IgG, NMR, NPs, SAXS
18  2020 Phytosterol Supplementation Could Improve Atherogenic and Anti-Atherogenic Apolipoproteins: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. CIs, CVDs, PS, RCTs, WMD
19  2020 The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well-controlled plasma LDL cholesterol. VLDL
20  2020 The nonalcoholic fatty liver disease-like phenotype and lowered serum VLDL are associated with decreased expression and DNA hypermethylation of hepatic ApoB in male offspring of ApoE deficient mothers fed a with Western diet. CD, NAFLD, WD
21  2020 The redox status of cysteine thiol residues of apolipoprotein E impacts on its lipid interactions. Cys, DMPC
22  2020 Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency. TG
23  2019 4-Phenylbutyrate protects against atherosclerotic lesion growth by increasing the expression of HSP25 in macrophages and in the circulation of Apoe-/- mice. 4-PBA, CVD, HSP, THP-1
24  2019 A comparative study of 3 alternative avian toxicity testing methods: Effects on hepatic gene expression in the chicken embryo. 17betaT, CYP1A4, Lb-FABP, qPCR, SCD, TCDD, VTG
25  2019 A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia. EPA, LDL-C, PS, TG
26  2019 Activity of Lipoprotein-Associated Enzymes in Indigenous Children Living at Different Altitudes. CETP, CH, PON1, SAC, TG
27  2019 Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function. AR, HDLs, IL
28  2019 Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide. ABCA1, ASCVD, HDL, i-FAMP
29  2019 Anti-oxidative function of follicular fluid HDL and outcomes of modified natural cycle-IVF. FF, HDL, MNC
30  2019 Apolipoprotein A-I enhances insulin-dependent and insulin-independent glucose uptake by skeletal muscle. ABCA1, AS160, HDL, HSkMCs, IR, IRS-1, PI3K
31  2019 Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach. LPL, TG
32  2019 Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease. AD, CNS, GABA, hiPSC
33  2019 Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up. CVD, MACE, OR, STEMI, VLDL
34  2019 Association between the LIPG polymorphisms and serum lipid levels in the Maonan and Han populations. HDL-C, LIPG, SNPs
35  2019 Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death. CAD, CI, HDL, MI
36  2019 Associations between serum apolipoproteins, urinary albumin excretion rate, estimated glomerular filtration rate, and diabetic retinopathy in individuals with type 2 diabetes. CI, eGFR, OR, SD, UACR
37  2019 Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits. CE, HDL, HDL-CE, VLDL/LDL
38  2019 Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number. AF, HDL, LCAT, SAA
39  2019 Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy. AD, CAA, ICH
40  2019 Calcium-induced transformation of cardiolipin nanodisks. CL, ND
41  2019 Candidate genes associated with the effect of rosiglitazone on glycemic control and cardiovascular system in the treatment of type 2 diabetes mellitus. BP, DEGs, GO, KEGG, NC, T2DM
42  2019 Changes in IGFBP-2 levels following a one-year lifestyle modification program are independently related to improvements in plasma apo B and LDL apo B levels. IGFBP
43  2019 Coconut oil intake and its effects on the cardiometabolic profile - A structured literature review. HDL-C, LDL-C
44  2019 Cod protein powder lowered serum nonesterified fatty acids and increased total bile acid concentrations in healthy, lean, physically active adults: a randomized double-blind study. Cod-RP, HDL
45  2019 Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention. CHD, ORs
46  2019 Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease. CVD, HDL-C, LDL-C
47  2019 Correlation Between the APOB rs1042034 SNP and Blood Lipid Characteristics of 2 Ethnic Groups in China. SNP, TG
48  2019 Do Postpartum Levels of Apolipoproteins Prospectively Predict the Development of Type 2 Diabetes in Women with Previous Gestational Diabetes Mellitus? GDM
49  2019 Dyslipidemia in diabetes: a population-based study in Bali. DM, HDL-C, HOMA-IR, LDL-C, NGT, TC, TG, WC
50  2019 Dysregulated Lipid Transport Proteins Correlate With Pathogenesis and Outcome in Severe Alcoholic Hepatitis. ABCA1, CD36, PON1, SAH, THP1
51  2019 Effects of Short-Term Hypothyroidism on the Lipid Transfer to High-Density Lipoprotein and Other Parameters Related to Lipoprotein Metabolism in Patients Submitted to Thyroidectomy for Thyroid Cancer. HDL, HDL-C, LDL
52  2019 Future perspectives of the pharmacological management of diabetic dyslipidemia. DPP-4is, GLP-1RA, HDL-C, LDL-C, SGLT2is, T2DM, TGs
53  2019 Glycoproteomic Profiling Provides Candidate Myocardial Infarction Predictors of Later Progression to Heart Failure. MI
54  2019 High density lipoprotein promotes nascent apolipoprotein A-V secretion from mRNA transfected cells. ---
55  2019 Impact of the Apolipoprotein E (epsilon) Genotype on Cardiometabolic Risk Markers and Responsiveness to Acute and Chronic Dietary Fat Manipulation. CRP, DVP-RI, HDL-C, LDL-C
56  2019 LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea. HDL, LCAT
57  2019 LIPG SNPs, their haplotypes and gene-environment interactions on serum lipid levels. LIPG, SNPs
58  2019 Longitudinal interaction between APOA5 -1131T>C and overweight in the acceleration of age-related increase in arterial stiffness through the regulation of circulating triglycerides. baPWV, BP, LDL
59  2019 Modified lipoproteins in periodontitis: a link to cardiovascular disease? A-I, CVD, HDL, LDL, PAF-AH, VLDL
60  2019 Neuron-Specific Apolipoprotein E4 (1-272) Fragment Induces Tau Hyperphosphorylation and Axonopathy via Triggering Endoplasmic Reticulum Stress. 4-PBA, AD, BiP, CHOP, ER
61  2019 Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function. AD
62  2019 New insights from liver-humanized mice on cholesterol lipoprotein metabolism and LXR-agonist pharmacodynamics in humans. CETP, HDL, LDL, LDLR, LHM, LXR, NOD, PCSK9
63  2019 Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment. ASCVD, HDL, LDL
64  2019 Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker. apoA-I, BCAA, HDL-C, LDL-C, NMR, PA, TG, TRL
65  2019 Rationale and protocol of the ENGAGE study: a double-blind randomized controlled preference trial using a comprehensive cohort design to measure the effect of a cognitive and leisure-based intervention in older adults with a memory complaint. BDNF, COMT
66  2019 Redox equilibrium of serum apolipoprotein E3: a buffering effect of disulfide-linked complexes against oxidative stress on apolipoprotein E3-containing lipoproteins. HDL, NR
67  2019 Repeatability and reproducibility of lipoprotein particle profile measurements in plasma samples by ultracentrifugation. HDL, ICC, LDL, LOD, LPPs, NMR, QC, TGs, UC
68  2019 Serum apolipoprotein B is associated with increased risk of metabolic syndrome among middle-aged and elderly Chinese: A cross-sectional and prospective cohort study. CIs, MetS
69  2019 Serum Biomarkers Related to Glucocorticoid-Induced Osteonecrosis of the Femoral Head: A Prospective Nested Case-Control Study. GC, ONFH, PINP
70  2019 Serum levels of proteins involved in amyloid-beta clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment. MCI
71  2019 Serum pentraxin 3 concentration in patients with type 2 diabetes and nonalcoholic fatty liver disease. NAFLD, PTX3, T2D, TG
72  2019 Shotgun proteomic analysis reveals proteome alterations in HDL of patients with cholesteryl ester transfer protein deficiency. ANGPTL3, CETP, HDL, HDL-C
73  2019 The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage. HDL
74  2019 The APOB loss-of-function mutation of Holstein dairy cattle does not cause a deficiency of cholesterol but decreases the capacity for cholesterol transport in circulation. CDC
75  2019 The atherogenic index (ATH index) as a potential predictive marker of idiopathic sudden sensorineural hearing loss: a case control study. AIP, ATH index, HDL-C, SSNHL, TC, TG
76  2019 The CXCL12 SNPs and their haplotypes are associated with serum lipid traits. CXCL12, SNPs
77  2019 The effects of isolated soy protein, isolated soy isoflavones and soy protein containing isoflavones on serum lipids in postmenopausal women: A systematic review and meta-analysis. MD, RCTs, TC, TG
78  2019 The Who, When, Why, and How of PET Amyloid Imaging in Management of Alzheimer's Disease-Review of Literature and Interesting Images. AD, CSF, PET, SUVR
79  2019 Usefulness of apolipoprotein B-depleted serum in cholesterol efflux capacity assays using immobilized liposome-bound gel beads. BDS, CA, CEC, HDL, HDL-C, LDL, PEG, TG, VLDL
80  2018 A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I. LPG, NF1
81  2018 A case of nephrotic syndrome showing contemporary presence of apolipoprotein E2homozygote glomerulopathy and membranous nephropathy-like findings modified by apolipoprotein E Toyonaka. EDDs, EM, MN
82  2018 A Novel Selective PPARalpha Modulator (SPPARMalpha), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice. FFA, HFD, HPLC, LPL, OFL, PHTG, SPPARMalpha, SPPARMalpha, TC, TG
83  2018 Acai (Euterpe oleracea Mart.) dietary intake affects plasma lipids, apolipoproteins, cholesteryl ester transfer to high-density lipoprotein and redox metabolism: A prospective study in women. TAC
84  2018 Anthropometric features as predictors of atherogenic dyslipidemia and cardiovascular risk in a large population of school-aged children. CC, HC, IOTF, LDL-C, MUAC, N_HDL-c, TC, WC, WHR, WHtR
85  2018 ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch's Membrane and Causes Its Structural Remodeling. AMD, EC
86  2018 ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels. CI, CIMT, LDL-C, OR, T2DM
87  2018 Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism. TRL
88  2018 Apolipoprotein E and Atherosclerosis: From Lipoprotein Metabolism to MicroRNA Control of Inflammation. ---
89  2018 Apolipoproteins C-II and C-III as nutritional markers unaffected by inflammation. CRP, RBP, RTPs, Tf, TTR
90  2018 Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia. 11 C-PiB, AD, CDR, CI, CU, FAQ, MCI, MCSA, OR, PET, SOB
91  2018 Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease. CHD, Fg, HDL-C, LDL-C, SYNTAX
92  2018 Association between the MGAT1 rs634501 polymorphism and serum lipid traits in the Chinese Han and Maonan ethnic groups. MGAT1, SNP
93  2018 Association of CPS1 rs1047891 SNP and serum lipid levels in two Chinese ethnic groups. CPS1, HCY, HDL-C, LDL-C, SNP
94  2018 Association of sleep duration with apolipoproteins and the apolipoprotein B/A1 ratio: the China health and nutrition survey. ---
95  2018 Association of the APOA1 rs964184 SNP and serum lipid traits in the Chinese Maonan and Han populations. APOA1, HDL-C, SNP, TG
96  2018 Association of the FRMD5 rs2929282 polymorphism and serum lipid profiles in two Chinese ethnic groups. FRMD5, HDL-C, SNP, TG
97  2018 Association of the LIPC rs1532085 SNP and serum lipid traits in the Chinese Maonan and Han populations. LDL-C, SNP, TC, TG
98  2018 Associations Between Dietary Antioxidant Intake and Markers of Atherosclerosis in Middle-Aged Women From North-Western Algeria. BMI
99  2018 Associations between epicardial adipose tissue, subclinical atherosclerosis and high-density lipoprotein composition in type 1 diabetes. EAT, HDL
100  2018 Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis. CV, HD, LDL